Product
Sutimlimab
2 clinical trials
2 indications
Indication
Cold Agglutinin SyndromeIndication
Cold Agglutinin DiseaseClinical trial
Cold Agglutinin Disease Real World Evidence RegistryStatus: Recruiting, Estimated PCD: 2028-11-02
Clinical trial
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Without a Recent History of Blood TransfusionStatus: Completed, Estimated PCD: 2021-12-03